http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2469734-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b3ab549c5c19a61fad9b39b86ab84e1 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-752 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185 |
| filingDate | 2010-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_448229636656ea7ad372f1b082758b27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09a2bbf4938d8799a3765f7551d85e5d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9508419a34e3ab93776d53b92b54ee8a |
| publicationDate | 2012-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2469734-C2 |
| titleOfInvention | Medication for treating accommodation disorders "stiak" |
| abstract | FIELD: medicine. n SUBSTANCE: method of treating accommodation disorders, including introduction of morning and evening compositions into conjunctival sac, with morning composition containing cytidine or digoxin, taufon or taurine, polyvinylpyrrolidone, menthol and rose water, and evening composition containing tropicamide, mezaton, digoxin or adenosine triphosphate, menthol and rose water and carrying out additionally aromatherapy with application of morning and evening compositions of essential oils, with morning composition containing essential oils of rosemary, lemon and geranium, and evening composition containing essential oils of bergamot, jasmine and orange, with specified component ratio. n EFFECT: method is efficient in treatment of accommodation disorders and reduces risk of development of side effects. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2676274-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2676303-C2 |
| priorityDate | 2010-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 71.